Clinical Trial Update: Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids. [Phase 3]

View source ↗

Summary

Phase 3 trial in de novo kidney transplant recipients comparing a once-daily regimen of everolimus, low-dose cyclosporine, and steroids to either steroid withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Everolimus (everolimus)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Novartis | Conditions: de Novo Kidney Transplant Recipients, Renal Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2013-11-14